AAO 2023: Dr. Shields Presents Phase 2 SC Belzupacap Sarotalocan Data

A Phase 2 Trial of Belzupacap Sarotalocan, a Targeted Investigational Therapy for Choroidal Melanoma via Suprachoroidal Administration